Physician
Oncology
Dr. Mark Fesen, MD
|
|
Give Review
Mark Fesen is an expert in the field of Oncology. He researched medicine at Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. Mark Fesen is a published doctor. He has 18 publications published. The most current publication "Application of the electrotopological state index to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors." He is registered with Medicare.
Publications
- Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with Cancer receiving chemotherapy.
- Safety and efficacy of alteplase for restoring function in occluded Central venous catheters: results of the cardiovascular thrombolytic to open occluded lines trial.
- Effects of DNA methylation on topoisomerase I and II cleavage activities.
- Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors.
- Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field Analysis (CoMFA) study.
- The site of antiviral action of 3-nitrosobenzamide on the infectivity process of human immunodeficiency virus in human lymphocytes.
- Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds.
- Hydroxylated aromatic inhibitors of HIV-1 integrase.
- Focused hyperthermia with a magnetic resonance imaging (MRI) unit and an interstitial grounded probe.
- Field-focusing hyperthermia and magnetic resonance imaging (MRI) with a grounded probe and a commercial MRI scanner.
- The effects of cis-dichlorodiammine platinum on alkaline density gradient centrifugation of poly(dA).poly(dT).
- Application of the electrotopological state index to QSAR Analysis of flavone derivatives as HIV-1 integrase inhibitors.
- (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase.
- Inhibitors of human immunodeficiency virus integrase.
- Specific interaction of camptothecin, a topoisomerase I inhibitor, with guanine residues of DNA detected by photoactivation at 365 nm.
- Intermolecular disintegration and intramolecular strand transfer activities of wild-type and mutant HIV-1 integrase.
- Mammalian topoisomerase II activity is modulated by the DNA minor groove binder distamycin in simian virus 40 DNA.
Schools
Rutgers Medical School
Roger Williams HospBrown U
National Cancer InstituteNih
Oral Roberts University School of Medicine
Rutgers University
Procedures Preformed
- Biopsy
- Cancer Counseling
- Cancer Pain Management
- Hematologic Disorder Treatment
- View All
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Oncology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Rutgers Robert Wood Johnson Medical School
Drug Facts
| NPI NUMBER | 1639149545 | |
| NPPES Provider LastName | FESEN | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 675303563 | |
| NPPES Provider State | KS | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 2638.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 171.0 | |
| Percent Opioid Claims | 6.48 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639149545 |
| Last Name Of The Provider | FESEN |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
Dr. Everard H. Hughes Jr., MD
 This Doctor is OpenDoctor Recommended.
|